Number of the records: 1  

Novel Nucleophilic Compounds with Oxime Group as Reactivators of Paraoxon-Inhibited Cholinesterases

  1. 1.
    SYSNO ASEP0342827
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleNovel Nucleophilic Compounds with Oxime Group as Reactivators of Paraoxon-Inhibited Cholinesterases
    Author(s) Musilová, L. (CZ)
    Jun, D. (CZ)
    Paleček, J. (DE)
    Církva, Vladimír (UCHP-M) RID, ORCID, SAI
    Musílek, K. (CZ)
    Paar, M. (CZ)
    Hrabinová, M. (CZ)
    Pohanka, M. (CZ)
    Kuca, K. (CZ)
    Source TitleLetters in Drug Design & Discovery - ISSN 1570-1808
    Roč. 7, č. 4 (2010), s. 260-264
    Number of pages5 s.
    Languageeng - English
    CountryUS - United States
    Keywordsacetylcholinesterase ; butyrylcholinesterase ; nerve agent
    Subject RIVCC - Organic Chemistry
    CEZAV0Z40720504 - UCHP-M (2005-2011)
    UT WOS000275929300006
    DOI10.2174/157018010790945823
    AnnotationNew cholinesterase reactivators are synthesized as potential antidotes for treatment of organophosphorus agent poisonings or as part of pseudo catalytic scavengers for improvement of the nerve agent prophylaxis. In this study, three novel potential cholinesterase reactivators (K064 - (E)-1-(pyridinium)-4-(2-hydroxyiminomethylpyridinium)-but-2-ene dibromide; K065 - (E)-1-(quinolinium)-4-(2-hydroxyiminomethylpyridinium)-but-2-ene dibromide; K066 - (E)-1-(isoquinolinium)-4-(2-hydroxyiminomethylpyridinium)-but-2-ene dibromide) were synthesized and tested for their potency to reactivate acetylcholinesterase (AChE, EC 3.1.1.3) and butyrylcholinesterase (BChE, 3.1.1.8) inhibited by pesticide paraoxon. As resulted, none from the synthesized compounds surpassed currently clinically used reactivators (pralidoxime, obidoxime and HI-6).
    WorkplaceInstitute of Chemical Process Fundamentals
    ContactEva Jirsová, jirsova@icpf.cas.cz, Tel.: 220 390 227
    Year of Publishing2011
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.